Review articles

• From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research

  José M. de la Torre Hernández, Elazer R. Edelman

  Rev Esp Cardiol. 2017;70:1121-33

• Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope

  Esther González-López, Ángela López-Sainz, Pablo Garcia-Pavia

  Rev Esp Cardiol. 2017;70:991-1004

• Diagnostic and Prognostic Value of CMR T1-Mapping in Patients With Heart Failure and Preserved Ejection Fraction

  Karl-Philipp Rommel, Christian Lücke, Philipp Lurz

  Rev Esp Cardiol. 2017;70:848-55

• Percutaneous Treatment of the Tricuspid Valve Disease: New Hope for the “Forgotten” Valve

  Francisco Campelo-Parada, Olivier Lairez, Didier Carrié

  Rev Esp Cardiol. 2017;70:856-66

• Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to “Omics” Technologies

  Rosalinda Madonna

  Rev Esp Cardiol. 2017;70:576-82

• Rationale for Cardio-Oncology Units

  Lara F. Nhola, Hector R. Villarraga

  Rev Esp Cardiol. 2017;70:583-9

• Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies

  Teresa López-Fernández, Paaladinesh Thavendiranathan

  Rev Esp Cardiol. 2017;70:487-95

• Current and Future Percutaneous Strategies for the Treatment of Acute and Chronic Heart Failure

  Ignacio J. Amat-Santos, Luis H. Varela-Falcón, William T. Abraham

  Rev Esp Cardiol. 2017;70:382-90

• Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure

  Cristina Sánchez-Enrique, Ulrich P. Jorde, José González-Costello

  Rev Esp Cardiol. 2017;70:371-81

• Three-dimensional Printed Cardiac Models: Applications in the Field of Medical Education, Cardiovascular Surgery, and Structural Heart Interventions

  Israel Valverde

  Rev Esp Cardiol. 2017;70:282-91

• Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk

  Sergio Raposeiras-Roubín, Virginia Triant

  Rev Esp Cardiol. 2016;69:1204-13

• New Oral Hypoglycemic Agents and Cardiovascular Risk. Crossing the Metabolic Border

  Belén Dalama, Jordi Mesa

  Rev Esp Cardiol. 2016;69:1088-97

• Transitions of Care Between Acute and Chronic Heart Failure: Critical Steps in the Design of a Multidisciplinary Care Model for the Prevention of Rehospitalization

  Josep Comín-Colet, Cristina Enjuanes, Josep Lupón, Miguel Cainzos-Achirica, Neus Badosa, José María Verdú

  Rev Esp Cardiol. 2016;69:951-61

• Embolic Protection Devices During TAVI: Current Evidence and Uncertainties

  Omar Abdul-Jawad Altisent, Rishi Puri, Josep Rodés-Cabau

  Rev Esp Cardiol. 2016;69:962-72

• Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy

  Fernando Dominguez, Uwe Kühl, Burkert Pieske, Pablo Garcia-Pavia, Carsten Tschöpe

  Rev Esp Cardiol. 2016;69:178-87

• Stress Computed Tomography Myocardial Perfusion Imaging: A New Topic in Cardiology

  Sara Seitun, Margherita Castiglione Morelli, Irilda Budaj, Sara Boccalini, Athena Galletto Pregliasco, Alberto Valbusa, Filippo Cademartiri, Carlo Ferro

  Rev Esp Cardiol. 2016;69:188-200

• The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy

  Juan Gómez, Julián R. Reguero, Eliecer Coto

  Rev Esp Cardiol. 2016;69:61-8

• Percutaneous Transcatheter Mitral Valve Replacement: Patient-specific Three-dimensional Computer-based Heart Model and Prototyping

  Beatriz Vaquerizo, Pascal Theriault-Lauzier, Nicolo Piazza

  Rev Esp Cardiol. 2015;68:1165-73

• Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease

  Lina Badimon, Blanca Oñate, Gemma Vilahur

  Rev Esp Cardiol. 2015;68:599-611

• Current Percutaneous Recanalization of Coronary Chronic Total Occlusion

  Masahisa Yamane

  Rev Esp Cardiol. 2012;65:265-77